Copenhagen-listed shares of Novo Nordisk plunged more than 21% on Tuesday after the Danish pharmaceutical company issued a profit warning, citing weaker-than-expected sales growth for its flagship drugs Wegovy and Ozempic in the United States. The announcement sent its New York-listed shares down over 20% in pre-market trading, wiping out…
On Tuesday, the International Monetary Fund (IMF) modestly raised its global growth predictions for 2025 and 2026, noting unexpectedly…
President Donald Trump said Tuesday that India could be subject to tariffs ranging between 20% and 25% as the…
Three vessels chartered by India’s Nayara Energy have sought to terminate their contracts, pressured by EU sanctions imposed on…
For two years, the American consumer has carried the economy. Even with interest rates at their highest level in…
Liquefied natural gas developers led a surge in US energy shares on Monday after the European Union committed to…
The economic recovery in Argentina, which began with a robust start in early 2025 after years of underperformance, is…
Brazilian bank BTG Pactual announced on Monday it agreed to buy HSBC operations in Uruguay for $175 million, the…